Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Targeting of albumin-embedded paclitaxel nanoparticles to tumors.

Karmali PP, Kotamraju VR, Kastantin M, Black M, Missirlis D, Tirrell M, Ruoslahti E.

Nanomedicine. 2009 Mar;5(1):73-82. doi: 10.1016/j.nano.2008.07.007. Epub 2008 Oct 1.

2.

Efficient delivery of therapeutic agents by using targeted albumin nanoparticles.

Kouchakzadeh H, Safavi MS, Shojaosadati SA.

Adv Protein Chem Struct Biol. 2015;98:121-43. doi: 10.1016/bs.apcsb.2014.11.002. Epub 2015 Mar 3. Review.

PMID:
25819278
3.

Protein nanoparticles as drug carriers in clinical medicine.

Hawkins MJ, Soon-Shiong P, Desai N.

Adv Drug Deliv Rev. 2008 May 22;60(8):876-85. doi: 10.1016/j.addr.2007.08.044. Epub 2008 Feb 7. Review.

PMID:
18423779
4.

Nanoparticle albumin-bound paclitaxel (ABI-007): a newer taxane alternative in breast cancer.

Moreno-Aspitia A, Perez EA.

Future Oncol. 2005 Dec;1(6):755-62. Review.

PMID:
16556053
5.

Treatment innovations for metastatic breast cancer: nanoparticle albumin-bound (NAB) technology targeted to tumors.

Lluch A, Alvarez I, Muñoz M, Seguí MÁ, Tusquets I, García-Estévez L.

Crit Rev Oncol Hematol. 2014 Jan;89(1):62-72. doi: 10.1016/j.critrevonc.2013.08.001. Epub 2013 Aug 21. Review.

PMID:
24071503
6.

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer.

Guarneri V, Dieci MV, Conte P.

Expert Opin Pharmacother. 2012 Feb;13(3):395-406. doi: 10.1517/14656566.2012.651127. Epub 2012 Jan 21. Review.

PMID:
22263900
7.

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.

Montero AJ, Adams B, Diaz-Montero CM, Glück S.

Expert Rev Clin Pharmacol. 2011 May;4(3):329-34. doi: 10.1586/ecp.11.7. Review.

PMID:
22114779
8.

Albumin-bound paclitaxel: a next-generation taxane.

Gradishar WJ.

Expert Opin Pharmacother. 2006 Jun;7(8):1041-53. Review.

PMID:
16722814
9.

Reinvention of chemotherapy: drug conjugates and nanoparticles.

Nguyen-Ngoc T, Raymond E.

Curr Opin Oncol. 2015 May;27(3):232-42. doi: 10.1097/CCO.0000000000000183. Review.

PMID:
25783982
10.

Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel.

Petrelli F, Borgonovo K, Barni S.

Expert Opin Pharmacother. 2010 Jun;11(8):1413-32. doi: 10.1517/14656561003796562. Review.

PMID:
20446855
11.

Clinical impact of serum proteins on drug delivery.

Kratz F, Elsadek B.

J Control Release. 2012 Jul 20;161(2):429-45. doi: 10.1016/j.jconrel.2011.11.028. Epub 2011 Dec 1. Review.

PMID:
22155554
12.

Unraveling the mysteries of serum albumin-more than just a serum protein.

Merlot AM, Kalinowski DS, Richardson DR.

Front Physiol. 2014 Aug 12;5:299. doi: 10.3389/fphys.2014.00299. eCollection 2014. Review.

Supplemental Content

Support Center